Evidence map›Paper›PMID 42180732›Full record

ArticleFrontiers in medicine2026

Evaluation of GPT-5.2 for melanoma detection across skin tones.

Katie L Frederickson, Samuel E Adunyah, Qingguo Wang

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Katie L FredericksonDepartment of Biochemistry, Cancer Biology, Neurosciences and Pharmacology, School of Medicine, Meharry Medical College, Nashville, TN, United States.
Samuel E AdunyahDepartment of Biochemistry, Cancer Biology, Neurosciences and Pharmacology, School of Medicine, Meharry Medical College, Nashville, TN, United States.
Qingguo WangDepartment of Biochemistry, Cancer Biology, Neurosciences and Pharmacology, School of Medicine, Meharry Medical College, Nashville, TN, United States.

Funding

The RCMI Program in Health Disparities Research at Meharry Medical College - SupplementU54MD007586 · NIMHD · MEHARRY MEDICAL COLLEGE · PI Samuel Evans Adunyah · 2017 to 2026
$48.2M
Diversity Center for Genome Research at MeharryUG3HG013248 · NHGRI · MEHARRY MEDICAL COLLEGE · PI SHANKER, ANIL · 2023 to 2023
$866k
Development and characterization of anti-P. gingivalis peptidesR16GM149359 · NIGMS · MEHARRY MEDICAL COLLEGE · PI Qingguo Wang · 2023 to 2026
$582k
NHGRI NIH HHS UG3 HG013248NIGMS NIH HHS R16 GM149359NIMHD NIH HHS U54 MD007586
6 · The paper itself

Abstract

Malignant melanoma (MM) is the most aggressive form of skin cancer, for which early detection is critical and strongly associated with improved survival outcomes. Recent advances in large language models (LLMs), such as ChatGPT and Gemini, present promising opportunities to support melanoma early screening and clinical decision-making. However, despite increasing interest in LLM-based dermatologic applications, their diagnostic reliability across different populations remains insufficiently characterized. In this study, we systematically evaluated the performance of GPT-5.2 across skin pigmentation groups using Milk10K, a clinically curated, publicly available dermatology dataset comprising paired dermoscopic and clinical close-up images with histopathology-confirmed diagnoses and standardized skin tone annotations. GPT-5.2 was assessed on two clinically relevant tasks: binary malignancy discrimination and top-3 differential diagnosis. A balanced subset of 460 lesions (92 per skin tone class) was randomly selected for evaluation. Across both tasks and imaging conditions, GPT-5.2 showed moderate diagnostic performance, with broadly consistent accuracy, F1 score, and Cohen's

Indexed as

ChatGPTdermoscopyGPT-5.2large language modelmelanoma diagnosisskintone

Identifiers

PMID42180732
PMCPMC13194033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.